|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
1.020 +0.010 (+0.990%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,924,457 | -2.280% | 2,992,689 | 2,375,027 | 2,506,522 | 1,925,190 |
| Cost of Sales | (1,756,698) | 0.775% | (1,743,180) | (1,447,825) | (1,607,397) | (1,344,526) |
| Gross Profit | 1,167,759 | -6.543% | 1,249,509 | 927,202 | 899,125 | 580,664 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (37,568) | 315.483% | (9,042) | 3,448 | (1,801) | 1,340 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 405 | -57.724% | 958 | 419 | 803 | 775 | |
| Profit / (Loss) before Taxation | 483,921 | -11.310% | 545,632 | 327,190 | 227,477 | (108,823) | |
| Taxation | (129,266) | -10.018% | (143,657) | (84,041) | (101,372) | 16,326 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 24,038 | -- | -- | |
| Non-controlling Interests | (57,334) | 50.199% | (38,172) | 23,606 | 55,448 | 84,621 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 297,321 | -18.274% | 363,803 | 290,793 | 181,553 | (7,876) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 123,979 | 10.453% | 112,246 | 104,907 | 156,706 | 185,378 |
| Depreciation & Amortisation | 429,303 | 8.181% | 396,838 | 340,803 | 384,511 | 371,540 |
| Directors' Emoluments | 3,611 | -1.177% | 3,654 | 6,105 | 8,489 | 8,769 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 19.000 | -17.391% | 23.000 | 18.000 | 11.000 | -0.500 |
| DPS (cts) | 4.156 | -- | 11.995 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 21.873% | -- | 52.151% | -- | -- | -- |
| Cash flow per share ($) | 0.497 | -- | 0.520 | 0.444 | 0.428 | 0.280 |
| NBV per share ($) | 0.846 | -- | 0.709 | 0.600 | 0.426 | 0.318 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 55,941 |
| %Change | -34.180% |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.881 |